A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiency

Richard L Wasserman
  • Expert Review of Clinical Immunology, February 2014, Taylor & Francis
  • DOI: 10.1586/1744666x.2014.891438
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1586/1744666x.2014.891438

The following have contributed to this page: Dr Richard L Wasserman